SOMATOSTATIN SECRETION FROM MONOLAYER-CULTURES OF NEONATAL RAT PANCREAS

被引:39
作者
PATEL, YC [1 ]
AMHERDT, M [1 ]
ORCI, L [1 ]
机构
[1] GENEVA MED SCH,INST HISTOL & EMBRYOL,GENEVA,SWITZERLAND
关键词
D O I
10.1210/endo-104-3-676
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monolayer cultures of neonatal rat pancreas have been characterized as an in vitro system for studying SRIF secretion. Marked 12- and 6-fold potentiation of SRIF release occurred with iV-2-O-dibutyryl cAMP monosodium salt and theophylline, respectively. High glucose (300 mg/dl) stimulated SRIF release, whereas galactose was without effect. Exogenous insulin did not alter SRIF release, and the SRIF responses to theophylline and glucose were unaffected by the addition of antiinsulin serum to neutralize the insulin released by these agents. Arginine evoked a significant 2-fold increase in SRIF release. Exogenous glucagon produced slight but not significant stimulation of SRIF release. However, after exposure of the cultures to antiglucagon serum to diminish the concentration of glucagon in contact with the SRIF cells, exogenous glucagon produced a marked enhancement of SRIF secretion. These data suggest that glucose, arginine, glucagon, N-2-Odibutyryl cAMP monosodium salt, and theophylline stimulate SRIF secretion, probably by direct effects on D cells or through mechanisms other than increased insulin secretion. Monolayer cultures of rat pancreas should provide a powerful in vitro system for studying pancreatic SRIF physiology. © 1979 by The Endocrine Society.
引用
收藏
页码:676 / 679
页数:4
相关论文
共 25 条
[1]   CYCLIC AMP-DEPENDENT STIMULATION OF SOMATOSTATIN SECRETION BY ISOLATED RAT ISLETS OF LANGERHANS [J].
BARDEN, N ;
ALVARADOURBINA, G ;
COTE, JP ;
DUPONT, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1976, 71 (03) :840-844
[2]   KINETICS OF IMMUNOREACTIVE INSULIN RELEASE IN OBESE HYPERGLYCEMIC LABORATORY RODENTS [J].
CAMERON, DP ;
STAUFFAC.W ;
AMHERDT, M ;
ORCI, L ;
RENOLD, AE .
ENDOCRINOLOGY, 1973, 92 (01) :257-264
[3]   IMMUNOREACTIVE SOMATOSTATIN IS PRESENT IN DISCRETE CELLS OF ENDOCRINE PANCREAS [J].
DUBOIS, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (04) :1340-1343
[4]  
Floyd J. C. Jr., 1977, Recent Progress in Hormone Research, V33, P519
[5]   REGULATION OF PANCREATIC INSULIN AND GLUCAGON-SECRETION [J].
GERICH, JE ;
CHARLES, MA ;
GRODSKY, GM .
ANNUAL REVIEW OF PHYSIOLOGY, 1976, 38 :353-388
[6]   SOMATOSTATIN - PHYSIOLOGICAL AND CLINICAL SIGNIFICANCE [J].
GUILLEMIN, R ;
GERICH, JE .
ANNUAL REVIEW OF MEDICINE, 1976, 27 :379-388
[7]  
HOKFELT T, 1975, ACTA ENDOCRINOL-COP, V80, P5
[8]   RELEASE OF IMMUNOREACTIVE SOMATOSTATIN FROM PANCREAS IN RESPONSE TO GLUCOSE, AMINO-ACIDS, PANCREOZYMIN-CHOLECYSTOKININ, AND TOLBUTAMIDE [J].
IPP, E ;
DOBBS, RE ;
ARIMURA, A ;
VALE, W ;
HARRIS, V ;
UNGER, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (03) :760-765
[9]  
ITO S, 1976, ENDOCRINE GUT PANCRE, P209
[10]   SOMATOSTATIN - HYPOTHALAMIC INHIBITOR OF ENDOCRINE PANCREAS [J].
KOERKER, DJ ;
RUCH, W ;
CHIDECKEL, E ;
PALMER, J ;
GOODNER, CJ ;
ENSINCK, J ;
GALE, CC .
SCIENCE, 1974, 184 (4135) :482-484